Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Minerva Med ; 109(6): 479-487, 2018 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-30256077

RESUMO

INTRODUCTION: Several studies have been designed to investigate the beneficial effects of probiotic supplementation on metabolic parameters and inflammation status in women with polycystic ovarian syndrome (PCOS), but results have been inconsistent. Herein, we perform a meta-analysis of randomized controlled trials (RCTs) to evaluate the effects of probiotic supplementation on glycemia control, lipidic profiles, weight loss and C-reactive protein (CRP) in women with PCOS. EVIDENCE ACQUISITION: MELINE, EMBASE, and Cochrane Library were searched for RCTs that investigated the effects of probiotic in women with PCOS. Two investigators independently performed the screening, data extraction, and methodological quality assessment. Data were pooled as mean differences (MDs) with 95% confidence intervals (CIs). The statistical heterogeneity was assessed with the I2 test. Sensitivity analyses were performed by the leave-one-out approach. EVIDENCE SYNTHESIS: From the literature search, 26 publications were screened and 6 RCTs involving 406 PCOS participants (aged 25-28.5 years) with follow-up period between 8-12 weeks were included. The pooled results showed that probiotic supplement significantly affected the levels of fasting blood insulin (FBI), quantitative insulin sensitivity check index (QUICKI), triglycerides (TG), and very low density lipoprotein-cholesterol (VLDL-C). However, no significant changes were found in other markers, including fasting plasma glucose, homeostatic model assessment-insulin resistance, total cholesterol, low-density lipoprotein-cholesterol, high-density lipoprotein-cholesterol, body weight, CRP, and dehydroepiandrosterone sulfate levels. The pooled result was robust after the sensitivity analysis. CONCLUSIONS: Our finding provides evidence that daily probiotic consumption has beneficial effects on decreasing FBI, TG, and VLDL-C, and increasing the QUICKI score in PCOS patients.


Assuntos
Glicemia/análise , Proteína C-Reativa/análise , Colesterol/sangue , Suplementos Nutricionais , Síndrome do Ovário Policístico/metabolismo , Síndrome do Ovário Policístico/terapia , Probióticos/uso terapêutico , Triglicerídeos/sangue , Redução de Peso , Feminino , Humanos , Metabolismo dos Lipídeos , Ensaios Clínicos Controlados Aleatórios como Assunto
2.
Zhonghua Yi Xue Za Zhi ; 87(10): 657-60, 2007 Mar 13.
Artigo em Chinês | MEDLINE | ID: mdl-17553299

RESUMO

OBJECTIVE: To explore the most common bowel frequency and the prevalence rates of functional bowel disorders among adolescents in China. METHODS: A questionnaire survey was conducted among 51,956 students from high and primary schools in 6 Chinese cities distributed in the whole China collected by stratified, randomized, cluster sampling to study the epidemiology of functional bowel disorders. RESULTS: (1) 88.05% +/- 0.28% of the students had bowel frequency between 1 - 2 times/day and 1 time/two days. Girl students were found to have a lower bowel frequency than boy students (P < 0.01). (2) The prevalence rates of irritable bowel syndrome, chronic constipation, and chronic diarrhea were 20.19% (10 490), 25.92% (13 467), and 8.77% (4557) respectively. CONCLUSION: (1) The normal bowel frequency among adolescents in China may be defined as bowel movements between 1 - 2 times per day and 1 time per two days. (2) Irritable bowel syndrome, chronic constipation and chronic diarrhea are common disorders among the adolescents in China.


Assuntos
Doenças Funcionais do Colo/epidemiologia , Inquéritos e Questionários , Adolescente , Criança , China/epidemiologia , Constipação Intestinal/epidemiologia , Diarreia/epidemiologia , Feminino , Humanos , Síndrome do Intestino Irritável/epidemiologia , Masculino , Prevalência
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...